Hey There : )
Unlisted Shares
Price Chart
1W
1M
1Y
MAX
High
-
Low
-
Return
-
East India Pharmaceutical Works Limited Essentials
As of September 09, 2024, East India Pharmaceutical Works, Unlisted share price is ₹78.00 per share and the face value is ₹10.00/share. The lot size of East India Pharmaceutical Works is 2600 shares. The 52-week high for East India Pharmaceutical Works stock price is ₹78, while the 52-week low is ₹61
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
It is the final profit left over after subtracting all operating and non operating items from net revenue.
It is the profit allocated to each outstanding share of common stock.
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
It measures companys total value, which includes market capitalization, debt and excludes cash.
It calculates the per share value of a company based on its equity available to common shareholders
Intrinsic value is the anticipated value of a company or stock determined through fundamental analysis. It is also referred to as the price a rational investor is willing to pay for an investment, given its level of risk.
It measures the amount of cash dividends distributed to equity shareholders relative to the market value per share.
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category is defined as a class or division of things regarded as having particular shared characteristics.
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
It shows the net flows of cash that are used to fund the company, which include transactions involving debt, equity, and dividends.
Average traded price is the average price at which a stock trades over a period of time.
East India Pharmaceutical Works Limited Growth
Compounded Sales Growth
Compounded Profit Growth
Return On Equity
Highlights
- First-of-their-kind Generic Drugs - East India Pharmaceutical Works developed several first-of-its-kind generic drugs in India, including the first indigenously developed antimalarial drug, the first generic version of metformin (anti-diabetic), and the first generic version of ramipril (anti-hypertensive). The company also has a strong pipeline of new products in development across various therapeutic areas.
- Revenue Growth - The company's revenue has experienced a substantial rise, climbing from ₹201.6 Cr in FY22 to ₹233.3 Cr in FY23, indicating a growth rate of 15.7%. Over the past five years, the company's revenue has consistently increased, achieving a compound annual growth rate (CAGR) of 9.03% from FY18 to FY23.
- Profitability -The company's profitability has consistently lagged behind industry standards. The EBIT margin, which stood at 3.6% in FY18, decreased to 2.9% in FY23, reflecting a Compound Annual Growth Rate (CAGR) of -4.65%. Although the net profit margin slightly increased from 0.4% in FY18 to 0.7% in FY23, the overall profitability was notably affected in FY23. This decline can be attributed to the rise in operating and other costs, impacting the overall profitability of the business.
- Investment Thesis - When comparing East India Pharmaceutical Works to industry peers, the average price-to-earnings (P/E) ratio is around 32.17x. After incorporating the respective discounts, the share price is estimated to be in the range of ₹57 to ₹61. Despite positive signals related to revenue growth and profitability, the company seems to be slightly overvalued. Additionally, the Indian Pharmaceutical Industry is dominated by established giants serving a similar target market, limiting potential opportunities for East India Pharmaceutical Works to thrive.
Business Rating
Our Team
₹
Quantity
Invest
₹
Min. Investment: ₹